首页 | 本学科首页   官方微博 | 高级检索  
检索        

克拉霉素、甲硝唑和兰索拉唑联合治疗幽门螺杆菌感染的临床疗效观察
引用本文:胡品津,李瑜元,陈湖,吴惠生,崔毅,黎庆宁.克拉霉素、甲硝唑和兰索拉唑联合治疗幽门螺杆菌感染的临床疗效观察[J].中华消化杂志,1997(4).
作者姓名:胡品津  李瑜元  陈湖  吴惠生  崔毅  黎庆宁
作者单位:中山医科大学一院,广州市第一人民医院
摘    要:目的:本文报道克拉霉素与甲硝唑及兰索拉唑联合应用治疗HP阳性的十二指肠溃疡。方法:59例符合条件的病人随机分成两个治疗组,其中30例口服充拉霉素250mg,甲硝唑400mg,兰索拉唑30mg。另一组29例口服克拉霉素500mg,甲硝唑400mg.兰索拉唑30mg,用法均为每日2次,疗程1周,继而口服兰索拉唑30mg,每日1次,共1周。疗程结束后1个月复查胃镜。结果:克拉霉素1000mg组HP根除率及溃疡愈合率分别为93.1%及89.7%,稍高于克拉霉素500mg组的76.7%及80.0%,但差异无显著性(P>0.05)。体外检测。克拉霉素HP耐药发生率仅4.8%,而甲硝唑HP耐药发生率则达33.3%,且甲硝唑耐药对HP根除率有较大影响。两组病人副反应总发生率为15.3%,克拉霉素两个剂量组间副反应发生率无明显差别,未发现严重副反应。病人依从性良好。结论:克拉霉素与甲硝唑及兰索拉唑合用1周疗法有较理想的溃疡愈合率与HP根除率;克拉霉素用量以每日1000mg为佳。

关 键 词:幽门螺杆菌,感染,十二指肠溃疡,药物疗法,联合

Clinical study of one week clarithromycin combination therapy for the treatment of H. pylori infection
Hu Pinjin,Li Yuyuan,Chen Minhu,et al..Clinical study of one week clarithromycin combination therapy for the treatment of H. pylori infection[J].Chinese Journal of Digestion,1997(4).
Authors:Hu Pinjin  Li Yuyuan  Chen Minhu  
Institution:Hu Pinjin,Li Yuyuan,Chen Minhu,et al. First Affiliated Hospital,Sun yat-Sen University of Medical Sciences and First Municipal Hospital of Guangzhou,510080
Abstract:Objectives: The efficacy of one week clarythromycin combination therapy in optimal dosage for the treatment of H. pylori infection was studied, and the influence of resistance to antibiotics on the eradication rate was also investigated. Methods: Fifty-nine patients with positive H. pylori active duodenal ulcer were recruited, H. pylori status was determinated by urease test, culture and histology before treatment and four weeks after cessation of all treatment, and resistance of H. pylori to clarithromycin and metronidazole was also tested. Patients were randomised into two groups: Group A received lanaoprazole 30mg, metronidazole 400mg and clarithromycin 250mg, each twice daily, and Group B lansoprazole 30mg combined with metronidazole 400mg and clarithromycin 500mg each twice daily. Combination therapy was administered for one week followed by lactsoprazole alone for a week further. Results: (1) Eradication rates of H. pylori were 76.7% (23/30) and 93.1% (27/28) in Group A and Group B, respectively (P>0.05); (2) Ulcer healing rates were 80.0% and 88.7 % in Group A and Group B, respectively (P>0.05): (3) Total side effect in 49 patients was 15.3%,all were mild and no statistical difference between the two groups; (4) Clarythromycin resistance . only accounted for 4.8 % whereas metronidazole resistance was 33.3% and eradication rate was much lower in patients with metronidazole resistance, Conclusions: clarithromycin combined with lansoprazole and metronida- zole for one week was highly effective in the cure of H. pylori and 500mg clarithromycin twice daily gave even better result.
Keywords:HP In fection Dudenal ulcer Drug therap  combination
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号